Mdrtb treatment regimens typically have a high pill burden, last 20 months or more and often lead to unsatisfactory outcomes. A list of references is included in a separate document however the majority of these recommendations are based on expert consensus. The treatment of mdr tb requires a long lasting drug exposure, and is also significantly associated with high rates of adverse drug events. Guidelines for treatment of drugsusceptible tuberculosis and patient. This study was carried out to detect preextensively drug resistant tb prexdrtb cases among the multidrug resistant tb mdrtb patients in bangladesh, as the early detection of prexdrtb can guide clinicians in the appropriate modification of mdrtb. The document presents comprehensive algorithms for diagnosis and treatmentmonitoring of pulmonary tb and mdrtb using rapid molecular techniques recommended by. Preextensively drug resistant tuberculosis prexdrtb. Highest death rates among mdr tb patients seen in african region 19% extensively drug resistant tb xdr tbmdr tb plus resistance to at least 1 fluoroquinolone and 1 secondline. Diagnosis of multidrugresistant tuberculosis and extensively. Contains information and advice about side effects, treatment completion, dot and others sources of support. Risk factors for poor treatment outcomes of 2266 multidrug. There were successive annual increments in new enrolments between 2010 and 2012 in at least 18 countries, and an increase of 50% in 2012 was seen in 15 countries, in comparison with 2011 table 2 and fig.
The sooner proper treatment commences, the sooner mdrtb will be contained in the community. We describe demographic characteristics and identify risk factors for poor outcome among patients with mdrtb in ho chi minh city hcmc, the most populous city in vietnam. We sought to determine the proportion of deaths during mdr tb treatment attrib. Epidemiology of multidrugresistant tuberculosis mdrtb. Multidrugresistant tuberculosis mdrtb is a form of tuberculosis tb infection caused by bacteria that are resistant to treatment with at least two of the most powerful firstline antitb medications drugs, isoniazid and rifampin. Nov 27, 2007 the emergence of multidrugresistant tuberculosis mdr tb and, more recently, extensively drugresistant tb xdr tb is widely considered a serious threat to global tb control. Worldwide, there were 650,000 multidrugresistant tuberculosis mdrtb cases in 2010, and in 2008 the world health organization estimated that 150,000 deaths occurred annually due to mdrtb. Mdrtb was more prevalent among the afghan patients. Pdf pdf icon 37k multidrugresistant tuberculosis mdr tb what is tuberculosis tb. Finding and treating multidrugresistant tb mdr tb in previously treated patients will help to improve the very poor outcomes in these patients. The scope of the who treatment guidelines for drug. This substance can then be replaced as advised in the guidelines 20, 33. Treatment of drugresistant tuberculosis american journal of respiratory and critical care medicine, 2019.
The global response to mdr tb and xdr tb enrolment on mdr tb treatment blue squares, 20092011. Some forms of tb are also resistant to secondline medications, and are called extensively drugresistant tb. Tags dadaab, east africa, kenya, mdr tb, somali refugees, tb an ounce of prevention. There is a paucity of evidence that assessed studies on the treatment of mdrtb, which focus on the effectiveness of the directly. Most treatment failures for patients with mdr tb are due to death during tb treatment. Mdrtb multidrug resistant tuberculosis ndoh national department of health nhls national health laboratory services phc primary health care ppm publicprivate mix.
Rapid and accurate detection of mdrtb is critical for appropriate treatment and controlling of tb. Translated versions are available to order as a pdf or printed resource. Improving quality of patient data for treatment of. Professor bengal college of pharmaceutical sciences and research 2. Amikacin is still within their guidance but this is now downgraded to a group c medication, with bedaquiline now being upgraded to a group a drug, whilst delamanid remains a group c drug. Predictors of poor outcomes vary in different regions. Multidrugresistant tuberculosis mdr tb is a global problem that many countries are challenged. Surgery has been applied to improve treatment success rates in mdrtb patients and a combined medical and surgical approach is increasingly being used to treat patients with mxdrtb.
Who treatment guidelines for rifampicin and multidrugresistant tuberculosis, 2018 update guideline development group gdg meeting 16 to 20 july 2018. The role of surgery in the treatment of pulmonary tb and. Tb treatment an overview of tb and standard tb treatment for newly diagnosed patients. Who consolidated guidelines on drugresistant tuberculosis treatment. Current treatment of multidrug resistant tuberculosis in. Multidrugresistant tuberculosis mdr tb is a form of tuberculosis tb infection caused by bacteria that are resistant to treatment with at least two of the most powerful firstline anti tb medications drugs, isoniazid and rifampin. A 911 month regimen with seven antibiotics has shown high success rates among selected mdrtb patients in different settings and is conditionally recommended by the world. Papua new guinea png is a high tb burden country with limited information on the magnitude of the mdr tb problem. Tb and multidrugresistant tb mdrtb through scalingup the appropriate use of whorecommended rapid molecular diagnostic techniques. The course contains seven modules and covers etiology and pathogenesis of tb, diagnosis and treatment, special situations. The term active tb drugsafety monitoring and management abbreviated as adsm describes a new tb programme component to provide for the active and systematic clinical and laboratory assessment of patients on treatment for xdr tb, or with new tb drugs or novel mdr tb regimens to detect, manage and report suspected or confirmed drug toxicities.
Who who treatment guidelines for rifampicin and multidrug. Modelling the effect of shortcourse multidrugresistant. This study was carried out to detect preextensively drug resistant tb prexdr tb cases among the multidrug resistant tb mdr tb patients in bangladesh, as the early detection of prexdr tb can guide clinicians in the appropriate modification of mdr tb. Background reliable estimates of the burden of multidrugresistant tuberculosis mdr tb are crucial for effective control and prevention of tuberculosis tb.
During this time most patients with mdr tb are admitted to hospital so that they can be closely monitored for adherence to. A survival guide for clinicians, third edition was created through a collaboration of the curry international tuberculosis center citc and the state of california department of public health, tuberculosis control branch cdph. Citc is a project of the university of california, san francisco, funded by the centers for. Because xdr tb is resistant to the most potent tb drugs, patients are left with treatment options that are much. When the diagnosis of ltb is established, there are two options for the management of contacts with exposure to mdr tb. Position statement on the continued use of the shorter mdrtb. Rapid and accurate detection of mdr tb is critical for appropriate treatment and controlling of tb. The sooner proper treatment commences, the sooner mdr tb will be contained in the community. Extensively drug resistant tb xdr tb is a rare type of mdr tb that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable secondline drugs i. It is accredited by the south african medical association and the norwegian medical association. The effect of surgical interventions on treatment outcomes for patients with drug resistant. The strategies described in this chapter are largely based on the recommendations from the 2011 update of guidelines for the programmatic management of drug. Mdr tb 20% among previously treated tb cases 50% of all mdr cases are estimated to occur in india and china globally, outcome data for mdr tb is limited.
Treatment of extrapulmonary tb and of tb in special situations 95. The treatment of mono and polydrugresistant tb is addressed in chapter 6. Mdrtb case management ann raftery, rn, bsn, phn, msc curry international tuberculosis center tb case management and contact investigation intensive march 1922, 2019 12 monitor clinical response to treatment sputum smear and culture ensure baseline sputum specimen for smear, culture and dst were obtained prior to mdr tb treatment start. The treatment of multidrug and rifampinresistant tuberculosis mdrrr tb is complex. The document presents comprehensive algorithms for diagnosis and treatment monitoring of pulmonary tb and mdr tb using rapid molecular techniques recommended by who. Why we must strengthen basic tb control to defeat drugresistant tb to many, the idea of living in a world where there is no effective treatment for tuberculosis tb seems unthinkable. Managing drugresistant tb is extremely challenging, and national guidelines call for treatment of drugresistant tb to be provided by or in close consultation with experts. New recommendations for the prompt detection and appropriate treatment of mdr tb cases will also improve access to lifesaving care. Which shows improvement in coverage and access to mdr tb treatment. This study identifies factors associated with the occurrence of mdrtb in patients who underwent firstline tb treatment in addis ababa city. Tb usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine. Mdrrr tb treatment guidelines in the coming years, building on a proven track record 2,2123,3234. The standard treatment consists of a combination of isoniazid, rifampicin.
Algorithm for laboratory diagnosis and treatmentmonitoring. Patients with mdr tb will have to take at least 5 different drugs, including a daily injection for 4 months 5 days a week. Treatment of multidrugresistant tuberculosis mdrtb. Background reliable estimates of the burden of multidrugresistant tuberculosis mdrtb are crucial for effective control and prevention of tuberculosis tb. Jan 17, 2017 antituberculosis drug resistance is a major public health problem that threatens the progress made in tuberculosis care and control worldwide.
Multidrugresistant tuberculosis, which is rare in germany around 100. Providing treatment for mdr ltbi can be accomplished in a resourcelimited setting, and contributed to preventing mdrtb disease. Preventive therapy for child contacts of multidrugresistant tuberculosis. Patients with mdrtb diagnosedregistered under ntp received support through the project staff, in addition to the routine domiciliary care provided by ntp staff. During this time most patients with mdr tb are admitted to hospital so that they can be closely monitored for adherence to treatment and to monitor any side effects. Management of contacts of multidrugresistant tuberculosis. Multidrugresistant tuberculosis treatment adherence in. Multidrug resistant tuberculosis mdrtb remains a serious public health problem with poor treatment outcomes.
The effectiveness of surgery in the management of pulmonary tb particularly mdrtb has not, however, been. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those affected. Health care providers can help prevent mdr tb by quickly diagnosing cases, following recommended treatment guidelines, monitoring patients response to treatment, and making sure therapy is completed. This is particularly the case with mdr tb where inadvertent treatment of active tb with a preventative regimen may result in the progression to even more highly resistant and difficult to treat tb. Treatment of multidrugresistant tuberculosis mdr tb it is accredited by the south african medical association and the norwegian medical association. The bacteria that cause tuberculosis tb can develop resistance to the antimicrobial drugs used to cure the disease. Epidemiology of multidrugresistant tuberculosis mdrtb in. Who treatment guidelines for drugresistant tuberculosis, 2016 update.
The history of tb and mdr tb treatment confirms strict hospitalization of patients as the accepted strategy, although depending on the geographical, economic and social settings, homebased care provided by trained lay and community health workers could achieve comparable results and, in theory. There is a paucity of evidence that assessed studies on the treatment of mdr tb, which focus on the effectiveness of the directly observed. Treatment for ltbi in contacts of mdrtb patients, federated states of micronesia, 20092012. Treatment outcomes for multidrugresistant tuberculosis. Background the union in collaboration with national tb programme ntp started the communitybased mdr tb care cbmdrtbc project in 33 townships of upper myanmar to improve treatment initiation and treatment adherence. Background the union in collaboration with national tb programme ntp started the communitybased mdrtb care cbmdrtbc project in 33 townships of upper myanmar to improve treatment initiation and treatment adherence. Improving quality of patient data for treatment of multidrug. This mdr tb online course exists as a free selflearning online tool in allowing physicians worldwide to learn and test their knowledge of mdr tb. The chuuk tb program implemented treatment of mdr ltbi with an 89% completion rate. The document replaces other who recommendations relating to the treatment of multidrug and rifampicinresistant tuberculosis mdrrrtb issued since 2011.
This chapter provides guidance on the strategies for the treatment of multidrug and extensively drugresistant tb mxdrtb, with emphasis on regimen design. The history of tb and mdrtb treatment confirms strict hospitalization of patients as the accepted strategy, although depending on the geographical, economic and social settings, homebased care provided by trained lay and community health workers could achieve comparable results and, in theory. Reported cases of mdrtb 2012 total cases tested for mdrtb 55 611 laboratoryconfirmed mdrtb cases 16 588 patients started on mdrtb treatment 14 143 9. Multidrugresistant tuberculosis mdrtb oxford academic. Treatment outcomes for multidrugresistant tuberculosis under. Multidrugresistant tuberculosis mdrtb is a global problem that many countries are challenged. Tuberculosis tb is a disease caused by bacteria that are spread from person to person through the air.
Over 400,000 new cases of mdrtb occur each year and, although their rates are currently unknown, xdrtb cases have been detected in every country where there is. This chapter provides guidance on the strategies for the treatment of multidrug and extensively drugresistant tb mxdr tb, with emphasis on regimen design. Communitybased mdrtb care project improves treatment. Download file the information we have provided here is not exhaustive and is aimed as a practical tool for aid in the management of patients with mdrtb. As a result, mdrtb has become a major focus for tb research in recent years 1, 2, with 480,000 new mdr. Mdr tb was more prevalent among the afghan patients. Collaborative group for the metaanalysis of individual patient data in mdrtb treatment2017, ahmad n, ahuja sd, et al. Over 400,000 new cases of mdr tb occur each year and, although their rates are currently unknown, xdr tb cases have been detected in every country where there is.
Multidrugresistant tuberculosis mdrtb, defined by resistance to isoniazid and rifampicin, the two frontline antimicrobial drugs used to treat tb, presents substantial barriers to the eradication of global tb due to challenges around diagnosis and successful treatment 1,2,3,4. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Patients may have different concurrent conditions, such as hiv infection or diabetes. Treatment success rates of multidrugresistant tuberculosis mdrtb is a key issue that cannot be ignored. In order to diagnose mdr tb, drugresistance testing should be conducted to determine if the tb strain is resistant to any drugs other than rifampicin and isoniazid nathanson et al. Guideline treatment of tuberculosi s in adults and children version 2. Vietnam is among the top 30 high burden of mdrtb countries. Treatment requires a combination of multiple agents and often needs to be individualized, taking numerous considerations into account 1,2. However, growing evidence shows that low treatment success rate and high rates of adverse events are associated with this regimen. Patients with mdr tb diagnosedregistered under ntp received support through the project staff, in addition to the routine domiciliary care provided by ntp staff. Providing treatment for mdr ltbi can be accomplished in a resourcelimited setting, and contributed to preventing mdr tb disease.
Who treatment guidelines for drug resistant tuberculosis. Pdf management of patients with multidrugresistant tuberculosis. The who consolidated guidelines on drugresistant tuberculosis treatment 2019, advise that that capreomycin and kanamycin should not be used in mdr tb. The course contains seven modules and covers etiology and pathogenesis of tb, diagnosis and treatment, special situations, patientphysician communication, treatment adherence, and tb infection. Mdr tb patients are required to stay in centralised dr tb hospitals, and b decentralising and deinstitutionalising services. Funding available for mdr tb has increased from usd 0. Papua new guinea png is a high tb burden country with limited information on the magnitude of the mdrtb problem. Another way to prevent getting mdr tb is to avoid exposure to known mdr tb patients in closed or crowded places such as hospitals. Financing for infrastructure improvements will additionally be made available both new construction and renovations to support infection control for mdrtb and tb in public. Of patients with multidrugresistant tuberculosis mdr tb, 50% complete treatment.
Treatment in developed countries is expensive and involves an individualized regimen based on drug susceptibility data and use of reserve drugs. The strengths of this guidance are that it draws from our extensive experience in guideline revisions, ipd collection, and ipdma. It means 85% of diagnosed cases or only 22% of the estimated incident mdrrrtb cases initiated treatment by the year. Tuberculosis tb is an infectious disease usually caused by mycobacterium tuberculosis mtb bacteria. The content of this guidance is meant for coordinators of mdrrr tb treatment who intend to share their experience in patient care to the benefit of national and global treatment policy following several datasharing principles table 1. The evaluation of a standard treatment regimen of antituberculosis drugs for patients. Emergence of drug resistant tuberculosis tb is a major obstacle in the tb control programme of bangladesh. Also, in 2016 about 19% of previously treated tb cases were estimated to have either rifampicin or multi drug resistant tb. The following health framework for management of dr tb patients has been proposed. The demonstrable value of ipd for developing who mdr rr tb treatment guidelines 1,48,49 and continued need for quality ipd to tackle the mdr rr tb epidemic underscore the importance of providing this support. The bacteria that cause tuberculosis tb can develop resistance to the antimicrobial drugs used to.
Most infections show no symptoms, in which case it is known as latent tuberculosis. The burden of drugresistant tuberculosis in papua new guinea. Treatment correlates of successful outcomes in pulmonary multidrugresistant tuberculosis. The burden of drugresistant tuberculosis in papua new. Tb and multidrugresistant tb mdr tb through scalingup the appropriate use of whorecommended rapid molecular diagnostic techniques. It means 85% of diagnosed cases or only 22% of the estimated incident mdr rr tb cases initiated treatment by the year. Treatment strategies for mdrtb and xdrtb companion.
Methods a crosssectional study was conducted in four png provinces. Guideline treatment of tuberculosis in adults and children. The mdr ltbi regimens were safe and well tolerated, and no tb cases occurred among persons treated for mdr ltbi. About 600,000 new cases of rifampicinresistant or multidrugresistant tuberculosis mdrrrtb are estimated to emerge each year, requiring treatment with secondline tb treatment regimens. Sep 27, 2018 the national mdr tb treatment program based on the recommendations from the 2011 update of guidelines for the programmatic management of drugresistant tuberculosis. Treatment success rates of multidrugresistant tuberculosis mdr tb is a key issue that cannot be ignored. In order to diagnose mdrtb, drugresistance testing should be conducted to determine if the tb strain is resistant to any drugs other than rifampicin and isoniazid nathanson et al. The programmatic management of multidrugresistant tuberculosis mdrtb is entirely based on a who recommended longterm, 1824 month lasting treatment regimen. Multidrugresistant tuberculosis mdrtb is a major threat to global tb control. Up to date, the mdrtb treatment outcome is not sufficiently understood in ethiopia. The number of patients commencing mdr tb treatment increased overall between 2009 and 2012. Multidrug resistant tb fact sheet western cape government. Patients with drugsusceptible tb must take treatment drugs for 68 months, while mdr tb treatment can take 2 years. Antituberculosis drug resistance is a major public health problem that threatens the progress made in tuberculosis care and control worldwide.
237 214 1192 69 1106 925 1521 1419 1315 447 54 1527 560 1105 980 1176 433 1247 1343 158 1117 30 1506 13 268 1490 1017 160 146 767 1384 1106 252 121 452 1336 1304 1025 740 588 438 1279 275 1213